We are monitoring the impact of COVID-19 on APAC Therapeutic Vaccines Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Therapeutic Vaccines Market Research Report – Segmented By Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) and Country (India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 59
Pages: 139

APAC Therapeutic Vaccines Market Size (2022 to 2027)

The size of the Asia-Pacific Therapeutic Vaccines Market was estimated at USD 734.73 Million in 2022. It is forecasted to be worth USD 3690.61 Million by 2027, growing at a CAGR of 38.1% between 2022 to 2027.

The market for therapeutic vaccines in the APAC region is expected to be driven by significant factors such as the increasing prevalence of chronic diseases such as Alzheimer's, breast cancer, and lung cancer cases. Increasing government funding for vaccine development, rising investments by leading market players, technological advancements, and new vaccine development centers across the region are further expected to propel market growth. In addition, therapeutic vaccinations have grown in popularity as illnesses like cancer and HIV have increased in emerging countries. Also, the technological advancements in HIV detection and expanded clinical trials for HIV and cancer vaccinations are two important reasons driving the APAC therapeutic vaccines market.

The key market players are focussing on the switch to therapeutic vaccinations as the need for effective therapy has risen alarming, which is expected to boost the market growth.  Other factors such as increasing healthcare spending, improving healthcare infrastructure, and favorable reimbursement factors significantly contribute to market growth. Furthermore, various pharmaceutical companies' increasing research and development activities are projected to provide lucrative growth opportunities for market growth. 

However, the lack of knowledge and limited resources in some countries are majorly limiting the market growth. In addition, high capital expenditures, strict regulatory restrictions, and expensive treatment costs are only a few factors that hamper market growth. Higher vaccination prices and a lack of therapeutic medication availability are restricting the therapeutic vaccines industry in the region. In addition, the stringent regulatory criteria for therapeutic vaccine approval impeded the APAC therapeutic vaccines market.

This research report on the APAC therapeutic vaccines market has been segmented and sub-segmented into the following categories:

By Disease Type: 

  • Autoimmune Disease
  • Cancer
  • Neurological Disease
  • Infectious Disease

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the APAC therapeutic vaccines market is one of the most promising regional markets in the global therapeutic vaccines market, and it is projected to register a prominent share during the forecast period. The regional market growth is propelled owing to the availability of advancing healthcare infrastructure, high prevalence of chronic diseases, and presence of key market players are boosting the market growth. Furthermore, two highly populated countries, China and India, contribute significantly to market growth and regional expansion. On the other hand, the major companies in the region are investing in vaccine development centers, which are expected to provide new vaccines to the market, allowing for market expansion.

China accounted for the largest share of the APAC market and is most likely to witness a dominant share during the forecast period. The technological advancements in the healthcare sector, increasing research and development activities, and high healthcare spending is fuelling the market growth. In addition, the rise of chronic diseases such as cancer, the discovery of novel vaccines, and the availability of superior healthcare services contribute to the country’s market growth.

India, on the other hand, is one of the fastest-growing countries in the Asia Pacific, contributing a significant portion of regional market growth while also improving the healthcare sector, increasing healthcare expenditure, and enacting supportive reimbursement policies, all of which contribute to the development of the Indian therapeutic vaccines market.

KEY MARKET PLAYERS:

Companies playing a significant role in the Asia Pacific therapeutic vaccines market covered in this report are GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Analysis Design                                                         

                2.3 Research Phases                                                      

                                2.3.1 Secondary Research                                           

                                2.3.2 Primary Research                                 

                                2.3.3 Econometric Modelling                                      

                                2.3.4 Expert Validation                                  

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 By Disease Type                                                       

                                5.1.1 Autoimmune Disease Vaccines                                      

                                5.1.2 Cancer Vaccines                                    

                                                5.1.2.1 Multikine                             

                                                5.1.2.2 PR1 Peptide                        

                                                5.1.2.3 TroVax                  

                                                5.1.2.4 CYT004-MelQbG10                           

                                5.1.3 Neurological Disease Vaccines                                        

                                                5.1.3.1 ACC- 001                               

                                                5.1.3.2 CAD 106                

                                                5.1.3.3 Parkinson's Disease Vaccine                        

                                                5.1.3.4 Alzheimer's Disease                        

                                5.1.4 Infectious Disease Vaccines                                             

                                                5.1.4.1 Hepatitis C                           

                                                5.1.4.2 HIV/AIDS                              

                                                5.1.4.3 Other Infectious Disease                               

  1. Geographical Analysis

                6.1 Introduction                                                               

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 GlaxoSMithKline plc.                                                              

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Merck and Company                                                              

                8.3 Bavarian Nordic                                                        

                8.4 CSL Limited                                                 

                8.5 Emergent Biosolutions Inc.                                                  

                8.6 Novartis AG                                                

                8.7 Johnson and Johnson                                                            

                8.8 MedImmune LLC                                                     

                8.9 Pfizer Inc.                                                    

                8.10 Sanofi Pasteur                                                        

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                           

  1. List of Tables
  2. List of Figures
  1. Asia-Pacific Therapeutic Vaccines Market, By Region, From 2022 - 2027 (USD Million)
  2. Asia-Pacific Therapeutic Vaccines Market, By Disease Type, From 2022 - 2027 (USD Million)
  3. Asia-Pacific Autoimmune Disease Vaccines Market, By Region, From 2022 - 2027 (USD Million)
  4. Asia-Pacific Cancer Vaccines Market, By Region, From 2022 - 2027 (USD Million)
  5. Asia-Pacific Neurological Disease Vaccines Market, By Region, From 2022 - 2027 (USD Million)
  6. Asia-Pacific Infectious Disease Vaccines Market, By Region, From 2022 - 2027 (USD Million)
  7. Asia-Pacific Cancer Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  8. Asia-Pacific Multikine Market, By Region, From 2022 - 2027 (USD Million)
  9. Asia-Pacific PR1 Peptide Market, By Region, From 2022 - 2027 (USD Million)
  10. Asia-Pacific TroVax Market, By Region, From 2022 - 2027 (USD Million)
  11. Asia-Pacific CYT004-MelQbG10 Market, By Region, From 2022 - 2027 (USD Million)
  12. Asia-Pacific Neurological Disease Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  13. Asia-Pacific ACC- 001 Market, By Region, From 2022 - 2027 (USD Million)
  14. Asia-Pacific CAD 106 Market, By Region, From 2022 - 2027 (USD Million)
  15. Asia-Pacific Parkinson's Vaccine Market, By Region, From 2022 - 2027 (USD Million)
  16. Asia-Pacific Alzheimer's Vaccine Market, By Region, From 2022 - 2027 (USD Million)
  17. Asia-Pacific Infectious Disease Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  18. Asia-Pacific Hepatitis C Vaccines Market, By Region, From 2022 - 2027 (USD Million)
  19. Asia-Pacific HIV/AIDS Vaccines Market, By Region, From 2022 - 2027 (USD Million)
  20. Asia-Pacific Other Infectious Disease Vaccines Market, By Region, From 2022 - 2027 (USD Million)
  21. China Therapeutic Vaccines Market, By Disease Type, From 2022 - 2027 (USD Million)
  22. India Therapeutic Vaccines Market, By Disease Type, From 2022 - 2027 (USD Million)
  23. Japan Therapeutic Vaccines Market, By Disease Type, From 2022 - 2027 (USD Million)
  24. South Korea Therapeutic Vaccines Market, By Disease Type, From 2022 - 2027 (USD Million)
  25. China Cancer Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  26. India Cancer Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  27. Japan Cancer Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  28. South Korea Cancer Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  29. China Neurological Disease Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  30. India Neurological Disease Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  31. Japan Neurological Disease Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  32. South Korea Neurological Disease Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  33. China Infectious Disease Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  34. India Infectious Disease Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  35. Japan Infectious Disease Vaccines Market, By Type, From 2022 - 2027 (USD Million)
  36. South Korea Infectious Disease Vaccines Market, By Type, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample